Strides Arcolab unit's Milan-based factory gets FDA OK

09/19/2013 | BioSpectrum Asia

The FDA has approved the drug facility of Strides Arcolab's Italian unit Beltapharm in Milan, allowing the company to enter the U.S. semisolid market. The facility will produce creams, ointments, semisolids and liquids, the drugmaker said in a statement. The facility is already cleared in Australia and the European Union.

View Full Article in:

BioSpectrum Asia

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Director, Payer Marketing
Avalere Health
Washington, DC
Actuary
Meridian Health Plan
Detroit, MI
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX